Lifecare ASA appoints Petter Nielsen as Chief Financial Officer

25 Feb 2026 07:00 CET

Bergen, Norway, 25 February 2026 -- Lifecare ASA (LIFE), a MedTech company
developing next-generation implantable continuous glucose monitoring (CGM)
technology, announces the appointment of Petter Nielsen as Chief Financial
Officer (CFO). Nielsen will assume the position on 1 April 2026.

Nielsen succeeds Renete Kaarvik, who will step down from her role as CFO with
her last working day on 31 March 2026.

Petter Nielsen brings extensive financial and capital markets experience from
listed growth companies and international industrial groups. He most recently
served as Group Chief Executive Officer of Gexcon AS (2022--2025), having
previously held the position as Group Chief Financial Officer in the same
company. Prior to that, he served as CFO of BerGenBio ASA, where he played a
central role in the company's listing on the Oslo Stock Exchange in 2017 and
in raising significant equity and grant funding. He has also held senior
finance roles in Vryhof/Deep Sea Mooring and Ernst & Young Transaction
Advisory Services.

Nielsen holds an MSc in Auditing and an MSc in Economics and Business
Administration from the Norwegian School of Economics (NHH) and is a State
Authorised Public Accountant.

Joacim Holter, CEO of Lifecare, comments:
"Petter brings strong financial leadership experience from publicly listed
growth companies and complex industrial organisations. His background in
capital markets, regulatory reporting and strategic financing will be highly
valuable as Lifecare moves into its next phase of clinical development and
prepares for commercial scale-up."

Holter continues:
"On behalf of the Board and management team, I would also like to thank Renete
for her important contributions to Lifecare during a transformative period for
the company, including strengthening our financial structure and supporting
key development milestones."

For further information, please contact:
Joacim Holter, CEO
Tel: +47 400 59 040
Email: joacim.holter@lifecare.no

About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR Article 17. The information was submitted for publication,
through the agency of the contact persons set out above, at 2026-02-25 07:00
CET.

More information:
Access the news on Oslo Bors NewsWeb site

666646_Lifecare ASA appoints Petter Nielsen as Chief Financial Officer.pdf